ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study
By
ASCO 2022 Conference Coverage
FEATURING
Morie Gertz
By
ASCO 2022 Conference Coverage
FEATURING
Morie Gertz
Login to view comments.
Click here to Login
Myeloma